US: Stocks end mostly down as health insurers slump

  • 📰 BusinessTimes
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

[NEW YORK] Wall Street stocks finished mostly lower with health insurers under pressure as markets continued to take a pause after a nearly two-month surge. Read more at The Business Times.

Wall Street stocks finished mostly lower with health insurers under pressure as markets continued to take a pause after a nearly two-month surge.[NEW YORK] Wall Street stocks finished mostly lower with health insurers under pressure as markets continued to take a pause after a nearly two-month surge.The broad-based S&P 500 slipped 0.1 per cent to close at 2,792.38, while the tech-rich Nasdaq Composite Index edged up 0.1 per cent to 7,554.51.

President Donald Trump's former attorney, Michael Cohen, revealed a litany of charges about his former boss in an explosive hearing that captivated political observers but did not appreciably move stocks. The bill is still a long way from becoming law, but the proposal indicates strengthening momentum for the issue among progressive Democrats.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 15. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

US stocks end mostly down as health insurers slumpNEW YORK: Wall Street stocks finished mostly lower on Wednesday (Feb 27) with health insurers under pressure as markets continued to take a pause ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Pharma stocks could see turbulence from US Senate drug-price hearingU.S. healthcare stocks could face more turbulence on Tuesday, after a bumpy early 2019, as top executives from some of the largest pharmaceutical ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »